Imhotex
Cambridge, GB · 1 known investors
Imhotex is a biotech company focused on drug development, managed by experienced professionals in therapeutic discovery and clinical advancement. The company appears to focus on translating scientific research into novel drug candidates.
Founders & leadership
RW
Robert W. SchroffChief Operating Officer
Board
DJ
David J. GraingerChairman
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- IMHOTEX LIMITED
- Company number
- 12443280
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 5 Feb 2020
- Registered office
- The Cambridge Partnership Dorothy Hodgkin Building, Babraham, Cambridge, CB22 3FH
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 28 Feb 2026 · next due 30 Nov 2027
- Confirmation statement
- last made up to 4 Feb 2026 · next due 18 Feb 2027
Current officers · 3
- The Cambridge Partnership Limited — corporate secretary, appointed 17 Feb 2020
- Francesco De Rubertis — director, appointed 14 Feb 2020
- David John Grainger — director, appointed 5 Feb 2020
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Imhotex do?
- Imhotex is a biotech company focused on drug development, managed by experienced professionals in therapeutic discovery and clinical advancement. The company appears to focus on translating scientific research into novel drug candidates.
- Who are Imhotex's investors?
- Imhotex's investors include Medicxi.
- Where is Imhotex headquartered?
- Imhotex is headquartered in Cambridge, GB.